TY - JOUR
T1 - Peri-procedural respiratory complications in patients undergoing pulmonary vein isolation under procedural sedation and analgesia
T2 - Incidence and predictive factors
AU - Homberg, Marloes
AU - Betz, Konstanze
AU - van Kuijk, Sander M.J.
AU - Luermans, Justin
AU - Joosten, E. A.
AU - Buhre, Wolfgang
AU - Schotten, Ulrich
AU - Vernooy, Kevin
AU - Linz, Dominik
AU - Bouman, Esther
N1 - Publisher Copyright:
© 2025 The Authors
PY - 2025/12/1
Y1 - 2025/12/1
N2 - Background and Objectives: Catheter ablation (CA) in patients with atrial fibrillation (AF) can be performed under procedural sedation and analgesia (PSA). Risk factors for respiratory complications during PSA are unclear. We aimed to determine the incidence and severity of respiratory complications during PSA and identify predictive factors for development of per-procedural respiratory complications. Methods: Patients with AF receiving PSA in the MUMC+ for CA were included. Respiratory complications were defined as the need of an oral/nasal airway, a non-rebreathing mask, high flow oxygen, a hypoxemic event or conversion to general anaesthesia. Results: In total 232 procedures (42.2 % cryoballoon ablation; 57.3 % RF ablation) were performed. Most patients were male (62.1 %), with a mean age of 64 ± 9.3 (mean ± SD), an activity level ≥ 4 METS (94.8 %) and paroxysmal AF (68.5 %). Respiratory complications occurred in 42.2 %. A multiple logistic regression model including sedation duration, age > 50 years, neck circumference > 40 cm, visceral fat percentage, self-reported tiredness, apnoea hypopnoea index (AHI), medical background of diagnosed sleep apnoea (OSAS) and chronic obstructive pulmonary disease (COPD) identified patients at risk with an AUROC 0.72, 95 % CI: 0.65–0.78. Conclusion: In patients with AF undergoing CA under PSA, per-procedural respiratory complications occur in 42.2 % of the cases. Duration of the PSA, a neck circumference > 40 cm, visceral fat percentage, tiredness, AHI, OSAS and COPD may help to identify patients at risk for per-procedural respiratory complications. Although age > 50 years is a recognized risk factor, this cut-off had limited discriminative value in our cohort, as most patients were older than 50.
AB - Background and Objectives: Catheter ablation (CA) in patients with atrial fibrillation (AF) can be performed under procedural sedation and analgesia (PSA). Risk factors for respiratory complications during PSA are unclear. We aimed to determine the incidence and severity of respiratory complications during PSA and identify predictive factors for development of per-procedural respiratory complications. Methods: Patients with AF receiving PSA in the MUMC+ for CA were included. Respiratory complications were defined as the need of an oral/nasal airway, a non-rebreathing mask, high flow oxygen, a hypoxemic event or conversion to general anaesthesia. Results: In total 232 procedures (42.2 % cryoballoon ablation; 57.3 % RF ablation) were performed. Most patients were male (62.1 %), with a mean age of 64 ± 9.3 (mean ± SD), an activity level ≥ 4 METS (94.8 %) and paroxysmal AF (68.5 %). Respiratory complications occurred in 42.2 %. A multiple logistic regression model including sedation duration, age > 50 years, neck circumference > 40 cm, visceral fat percentage, self-reported tiredness, apnoea hypopnoea index (AHI), medical background of diagnosed sleep apnoea (OSAS) and chronic obstructive pulmonary disease (COPD) identified patients at risk with an AUROC 0.72, 95 % CI: 0.65–0.78. Conclusion: In patients with AF undergoing CA under PSA, per-procedural respiratory complications occur in 42.2 % of the cases. Duration of the PSA, a neck circumference > 40 cm, visceral fat percentage, tiredness, AHI, OSAS and COPD may help to identify patients at risk for per-procedural respiratory complications. Although age > 50 years is a recognized risk factor, this cut-off had limited discriminative value in our cohort, as most patients were older than 50.
KW - Atrial fibrillation
KW - Catheter ablation
KW - Procedural sedation and analgesia
KW - Respiratory complications
UR - https://www.scopus.com/pages/publications/105018638554
U2 - 10.1016/j.ijcha.2025.101822
DO - 10.1016/j.ijcha.2025.101822
M3 - Article
AN - SCOPUS:105018638554
SN - 2352-9067
VL - 61
SP - 1
EP - 8
JO - IJC Heart and Vasculature
JF - IJC Heart and Vasculature
M1 - 101822
ER -